Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension

Ultrastructural changes of blood cells in with patients with hypertension of 1-2-degree, in patients with diabetes mellitus type 2 at compensation and subcompensation phase as well as in patients with diabetes mellitus and hypertension during correction of blood pressure with losartan was defined. I...

Full description

Saved in:
Bibliographic Details
Main Authors: Pertseva N.O., Turlyun T.S.
Format: Article
Language:English
Published: Dnipro State Medical University 2013-06-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://medpers.dsma.dp.ua/issues/2013/N2/31-40.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850058909245505536
author Pertseva N.O.
Turlyun T.S.
author_facet Pertseva N.O.
Turlyun T.S.
author_sort Pertseva N.O.
collection DOAJ
description Ultrastructural changes of blood cells in with patients with hypertension of 1-2-degree, in patients with diabetes mellitus type 2 at compensation and subcompensation phase as well as in patients with diabetes mellitus and hypertension during correction of blood pressure with losartan was defined. It is shown that in patients with hypertension of 1-2-degree relative content of activated platelets does not differ from the normal level. In patients with diabetes mellitus type 2 at compensation or subcompensation phase increase of degree of platelet activation, regardless of presence (150.9%) or absence of hypertension (141.5%) is observed. Conducted antihyper¬tensive therapy does not affect the spontaneous activation of platelets within 1 year. In patients with hypertension potential aggregation of platelets is the most sensitive element of platelet hemostasis damage, which can be normalized beginning with 6-th month of losartan treatment. In patients with diabetes mellitus type 2 with hypertension elevation of platelet aggregation is the most significant (75.4%) and a reliable effect of antihypertensive therapy on limitation of platelet aggregation is achieved in 9 months of treatment. The degree of platelet degranulation is not different from the norm in patients with hypertension and significantly elevated in patients with diabetes mellitus type 2 (by 81.0%), during 1-year observation a constant level of the parameter is revealed. In the group of patients with diabetes mellitus and hypertension, where the original content of degranulated platelets is sharply increased (by 76.2%), a significant positive dynamics in the course of treatment with losartan is observed.
format Article
id doaj-art-e8753cefc5f247a5a6c8febec7c2dfde
institution DOAJ
issn 2307-0404
2307-0404
language English
publishDate 2013-06-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-e8753cefc5f247a5a6c8febec7c2dfde2025-08-20T02:51:00ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042307-04042013-06-011823140Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertensionPertseva N.O.0Turlyun T.S. 1SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»Ultrastructural changes of blood cells in with patients with hypertension of 1-2-degree, in patients with diabetes mellitus type 2 at compensation and subcompensation phase as well as in patients with diabetes mellitus and hypertension during correction of blood pressure with losartan was defined. It is shown that in patients with hypertension of 1-2-degree relative content of activated platelets does not differ from the normal level. In patients with diabetes mellitus type 2 at compensation or subcompensation phase increase of degree of platelet activation, regardless of presence (150.9%) or absence of hypertension (141.5%) is observed. Conducted antihyper¬tensive therapy does not affect the spontaneous activation of platelets within 1 year. In patients with hypertension potential aggregation of platelets is the most sensitive element of platelet hemostasis damage, which can be normalized beginning with 6-th month of losartan treatment. In patients with diabetes mellitus type 2 with hypertension elevation of platelet aggregation is the most significant (75.4%) and a reliable effect of antihypertensive therapy on limitation of platelet aggregation is achieved in 9 months of treatment. The degree of platelet degranulation is not different from the norm in patients with hypertension and significantly elevated in patients with diabetes mellitus type 2 (by 81.0%), during 1-year observation a constant level of the parameter is revealed. In the group of patients with diabetes mellitus and hypertension, where the original content of degranulated platelets is sharply increased (by 76.2%), a significant positive dynamics in the course of treatment with losartan is observed.http://medpers.dsma.dp.ua/issues/2013/N2/31-40.pdfarterial hypertensiondiabetes mellitus type 2ultrastructure of platelets and white blood cellslosartan
spellingShingle Pertseva N.O.
Turlyun T.S.
Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension
Medičnì Perspektivi
arterial hypertension
diabetes mellitus type 2
ultrastructure of platelets and white blood cells
losartan
title Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension
title_full Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension
title_fullStr Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension
title_full_unstemmed Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension
title_short Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension
title_sort effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension
topic arterial hypertension
diabetes mellitus type 2
ultrastructure of platelets and white blood cells
losartan
url http://medpers.dsma.dp.ua/issues/2013/N2/31-40.pdf
work_keys_str_mv AT pertsevano effectoflosartanontheultrastructuralmorphologyofbloodcellsinpatientswithdiabetesmellitusandhypertension
AT turlyunts effectoflosartanontheultrastructuralmorphologyofbloodcellsinpatientswithdiabetesmellitusandhypertension